Skip to main content
P

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Filings indexed 792 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings
2026-05-07 English
Disruption of Operations
Regulatory Filings
2026-04-30 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings
2026-04-30 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-15 English
Bagging/Receiving of orders/contracts
Regulatory Filings
2026-04-11 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings
2026-04-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.